Skip to content
Research Article Open access CC BY 4.0

Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda

Kiguli James Mukasa, Itabangi Herbert, Atwine Daniel, Kibuka Livingstone Sserunkuma, Bazira Joel, Byarugaba Frederick

Microbiology Research Journal International · pp. 322–331 · Published 6 Nov 2014

10.9734/BMRJ/2015/13804

Abstract

Aims: To identify the Candida species that cause vulvovaginal candidiasis and determine their antifungal susceptibility patterns. Study Design: This was a cross-sectional study.  Place and Duration of Study: The study was conducted at the antenatal clinic of Mbarara Regional Referral Hospital in Mbarara Municipality, between December 2012 and February 2013. Methods: High vaginal swabs from 456 pregnant women were subjected to microscopy and culture on Sabouraud Dextrose Agar. Candida isolates were identified by the germ tube and Analytical profile index (API® Candida) tests. Susceptibility to fluconazole, itraconazole and voriconazole was determined by the Etest strips and for clotrimazole and nystatin by the disc diffusion method on Mueller Hinton agar supplemented with 2%w/v glucose and 0.5µg/ml methylene blue dye. Results: Of the 456 High vaginal swabs cultured, 207 grew Candida species. Species distribution was as follows: C. albicans (78.95%), C. glabrata (14.35%), C. krusei (3.35%), C. tropicalis (1.44%), C. famata (0.96%), C. parapsilosis (0.48%) and C. lusitaniae (0.48%). Resistance to nystatin was only observed in 0.61% of C.albicans. Resistance to clotrimazole was observed in 50%, 36.67% and 0.61% of C. famata, C. glabrata and C. albicans respectively. C. krusei showed a high resistance of 71.43% to fluconazole. C. glabrata, C. krusei, C. famata and C. lusitaniae exhibited 100% resistance to itraconazole. Resistance to voriconazole of less than 11% was exhibited by only C. albicans and C. glabrata. Conclusion: C.albicans was susceptible to most antifungal agents tested except itraconazole and voriconazole. All isolates were susceptible to nystatin except less than 1% of Candida albicans. Non-albicans demonstrated resistance to some drugs especially itraconazole. We recommend use of Nystatin for empirical management of vulvovaginal candidiasis among pregnant women.

Antifungal susceptible resistant vulvovaginal candidiasis Candida species

Cited by 44

The Epidemiology of Microbial Keratitis in South Western Uganda

Simon Arunga · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · 2020

Asymptomatic Bacteriuria and Candida Colonization among Pregnant Women in a District Hospital in Eastern Uganda

Bakandonda Fredrick, M. Shadrack, Nakate Prossy · Journal of Advances in Medicine and Medical Research · 2019

Comparative Investigation of the Sensitivity of Candida Fungi Isolated From Vulvovaginal Candidiasis to Nystatin and Teucrium polium Smoke Product

Marzieh Akbarzdeh, B. Bonyadpour, K. Pakshir · International Journal of Women's Health and Reproduction Sciences · 2018

Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology

H. Willems, David J. Lowes, Katherine S. Barker · Infection and Immunity · 2018

Bilateral Candida keratitis in an HIV patient with asymptomatic genitourinary candidiasis in Uganda

S. Arunga, T. Kwaga, A. Leck · Medical Mycology Case Reports · 2018

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

44

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.